CLINICAL_TRIALS
trial_result
· 2017-05-18
Clinical Trial Update: An Efficacy and Safety Study of Tocilizumab (RoActemra/Actemra) in Participants With Giant Cell Arteritis (GCA) [Phase 3]
Summary
Phase 3 clinical trial evaluating efficacy and safety of tocilizumab (RoActemra/Actemra) in Giant Cell Arteritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Giant Cell Arteritis | Phase 3 | Status: COMPLETED | Results posted: 2017-05-18